Gyre Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2015 | $38.1M | $69.5M | $29.1M |
| FY2016 | $22.0M | $38.1M | $10.3M |
| FY2017 | $8.7M | $39.5M | $14.5M |
| FY2018 | $5.0M | $124.9M | $31.2M |
| FY2019 | $30.2M | $98.6M | $15.4M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2015 | $38.1M | $69.5M | $29.1M |
| FY2016 | $22.0M | $38.1M | $10.3M |
| FY2017 | $8.7M | $39.5M | $14.5M |
| FY2018 | $5.0M | $124.9M | $31.2M |
| FY2019 | $30.2M | $98.6M | $15.4M |